NASS 2018 Annual Meeting

MiMedx Group Inc. 

Booth 1402

Marietta, GA  
      United States

MiMedx® is a biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental allografts and patent-protected processes for multiple sectors of healthcare. "Innovations in Regenerative Medicine" is the framework behind our mission to provide physicians with products and tissues to help the body heal itself. MiMedx is the leading supplier of placental tissue allografts, as we approach supplying over 1 million allografts for applications in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Pain Management, Ophthalmic and Dental sectors of healthcare.





Our flagship product, AmnioFix® dehydrated human amnion/chorion membrane (dHACM) allograft, is uniquely processed through the Company’s patented PURION® process, providing an easy to use, shelf-stable graft that modulates inflammation and offers barrier and surgical reconstructive properties for spinal procedures.



Product Categories

- Allografts
- Biomaterials